Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6442)
All Articles published online
|
Publishing Process of This Article
|
Jan 27, 2018 (publication date) through Apr 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ayoub F, Trillo-Alvarez C, Morelli G, Lascano J. Risk factors for hepatic steatosis in adults with cystic fibrosis: Similarities to non-alcoholic fatty liver disease. World J Hepatol 2018; 10(1): 34-40 [PMID: 29399276 DOI: 10.4254/wjh.v10.i1.34] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v10/i1/34.htm |
| Number | Citing Articles |
| 1 |
Katja Glutig, Paul-Christian Krüger, Theresa Oberreuther, Ulf Teichgräber, Michael Lorenz, Hans-Joachim Mentzel, Martin Krämer. A novel free-breathing abdominal RAVE T2/T1 hybrid MRI sequence in patients with cystic fibrosis: Preliminary results. European Journal of Radiology 2022; 154: 110454 doi: 10.1016/j.ejrad.2022.110454
|
| 2 |
Anna Bertolini, Frank A. J. A. Bodewes, Mordechai Slae, Michael Wilschanski. Cystic Fibrosis. Respiratory Medicine 2020; : 299 doi: 10.1007/978-3-030-42382-7_14
|
| 3 |
Jessica M. Shape, Marc A. Sala. Nutrition management in adults with cystic fibrosis. Nutrition in Clinical Practice 2022; 37(2): 256 doi: 10.1002/ncp.10842
|
| 4 |
Lenycia de Cassya Lopes Neri, Miriam Isabel Souza dos Santos Simon, Valéria Laguna Salomão Ambrósio, Eliana Barbosa, Monique Ferreira Garcia, Juliana Ferreira Mauri, Renata Rodrigues Guirau, Mirella Aparecida Neves, Carolina de Azevedo Pedrosa Cunha, Marcelo Coelho Nogueira, Anna Carolina Di Creddo Alves, Jocemara Gurmini, Maria de Fatima Servidoni, Matias Epifanio, Rodrigo Athanazio. Brazilian Guidelines for Nutrition in Cystic Fibrosis. Einstein (São Paulo) 2022; 20 doi: 10.31744/einstein_journal/2022RW5686
|
| 5 |
Tanvi Patel, Kimberly McBennett, Senthilkumar Sankararaman, Teresa Schindler, Krithika Sundaram, Nori Mercuri Minich, Sindhoosha Malay, Katherine Kutney. Impact of elexacaftor/tezacaftor/ivacaftor on lipid and fat‐soluble vitamin levels and association with body mass index. Pediatric Pulmonology 2024; 59(3): 734 doi: 10.1002/ppul.26823
|
| 6 |
Katherine Kutney, Shannon B Donnola, Chris A Flask, Rose Gubitosi-Klug, MaryAnn O’Riordan, Kimberly McBennett, Thomas J Sferra, Beth Kaminski. Lumacaftor/ivacaftor therapy is associated with reduced hepatic steatosis in cystic fibrosis patients. World Journal of Hepatology 2019; 11(12): 761-772 doi: 10.4254/wjh.v11.i12.761
|
| 7 |
Amanda Oliva Gobato, Ana Carolina Junqueira Vasques, Antonio Fernando Ribeiro, Roberto Massao Yamada, Gabriel Hessel. PREVALENCE OF HEPATIC STEATOSIS AMONG CHILDREN AND ADOLESCENTS WITH CYSTIC FIBROSIS AND ITS ASSOCIATION WITH NUTRITIONAL STATUS. Revista Paulista de Pediatria 2019; 37(4): 435 doi: 10.1590/1984-0462/;2019;37;4;00007
|
| 8 |
Tianhao Zhou, Debjyoti Kundu, Jonathan Robles-Linares, Vik Meadows, Keisaku Sato, Leonardo Baiocchi, Burcin Ekser, Shannon Glaser, Gianfranco Alpini, Heather Francis, Lindsey Kennedy. Feedback Signaling between Cholangiopathies, Ductular Reaction, and Non-Alcoholic Fatty Liver Disease. Cells 2021; 10(8): 2072 doi: 10.3390/cells10082072
|
| 9 |
Sabina Wiecek. Cystic Fibrosis - Heterogeneity and Personalized Treatment. 2020; doi: 10.5772/intechopen.89306
|
| 10 |
Fares Ayoub, Hechu Li, Charles Blay, Cesar Trillo‐Alvarez, Jorge Lascano, Giuseppe Morelli. Multidisciplinary Care for Cystic Fibrosis Liver Disease: Where Does the Adult Hepatologist Fit In?. Clinical Liver Disease 2019; 14(5): 187 doi: 10.1002/cld.845
|
| 11 |
Katherine A. Kutney, Zahrae Sandouk, Marisa Desimone, Amir Moheet. Obesity in cystic fibrosis. Journal of Clinical & Translational Endocrinology 2021; 26: 100276 doi: 10.1016/j.jcte.2021.100276
|
| 12 |
Anan A. Abu Rmilah, Wei Zhou, Scott L. Nyberg. Hormonal Contribution to Liver Regeneration. Mayo Clinic Proceedings: Innovations, Quality & Outcomes 2020; 4(3): 315 doi: 10.1016/j.mayocpiqo.2020.02.001
|
| 13 |
Sabina Więcek, Halina Woś, Andrzej Pogorzelski, Bożena Kordys-Darmolinska, Henryk Mazurek, Urszula Grzybowska-Chlebowczyk. Assessment of Selected Parameters of Liver Fibrosis and Inflammation in Patients with Diagnosed Cystic Fibrosis. Mediators of Inflammation 2020; 2020: 1 doi: 10.1155/2020/5696185
|
| 14 |
Thomas Boat, Elizabeth Hente, William Hardie, Rhonda Szczesniak, Emrah Gecili, Grace Zhou, Jacqueline Taylor, Raouf Amin. Body composition and functional correlates of CF youth experiencing pulmonary exacerbation and recovery. Pediatric Pulmonology 2023; 58(2): 457 doi: 10.1002/ppul.26207
|
| 15 |
Johann Colomba, Silvia R. Netedu, Catherine Lehoux-Dubois, Adèle Coriati, Valérie Boudreau, François Tremblay, Kenneth Cusi, Rémi Rabasa-Lhoret, Julio A. Leey, Wenjun Ding. Hepatic enzyme ALT as a marker of glucose abnormality in men with cystic fibrosis. PLOS ONE 2019; 14(7): e0219855 doi: 10.1371/journal.pone.0219855
|
| 16 |
Almudena Marinero Martínez-Lázaro, Rosa María Girón Moreno, Fernando Casals Seoane, Óscar Cano-Valderrama, Luisa García-Buey. Cystic fibrosis with liver involvement in adults has a benign course. Results from a tertiary referral centre cohort. Revista Española de Enfermedades Digestivas 2022; 114 doi: 10.17235/reed.2022.9289/2022
|
| 17 |
Zahra Namkhah, Fatemeh Naeini, Alireza Ostadrahimi, Helda Tutunchi, Mohammad Javad Hosseinzadeh‐Attar. The association of the adipokine zinc‐alpha2‐glycoprotein with non‐alcoholic fatty liver disease and related risk factors: A comprehensive systematic review. International Journal of Clinical Practice 2021; 75(7) doi: 10.1111/ijcp.13985
|
| 18 |
|
| 19 |
Zaina Issa, Sophie Gohy, Francis Zech, Pamela Baldin, Bénédicte Delire, Géraldine Dahlqvist. Prevalence and characteristics of cystic fibrosis liver disease: a study highlighting the lack of histological diagnosis. Clinics and Research in Hepatology and Gastroenterology 2022; 46(9): 101977 doi: 10.1016/j.clinre.2022.101977
|
| 20 |
Zachary M. Sellers, David N. Assis, Shruti M. Paranjape, Meghana Sathe, Frank Bodewes, Melissa Bowen, Marco Cipolli, Dominique Debray, Nicole Green, Kara S. Hughan, William R. Hunt, Julio Leey, Simon C. Ling, Giuseppe Morelli, Daniel Peckham, Rebeca S. Pettit, Alexander Philbrick, Janis Stoll, Kay Vavrina, Stacy Allen, Tara Goodwin, Sarah E. Hempstead, Michael R. Narkewicz. Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendations. Hepatology 2024; 79(5): 1220 doi: 10.1097/HEP.0000000000000646
|
| 21 |
Sabina Wiecek, Piotr Fabrowicz, Halina Wos, Bożena Kordys-Darmolinska, Maciej Cebula, Katarzyna Gruszczynska, Urszula Grzybowska-Chlebowczyk, Zhengwen Liu. Assessment of Liver Fibrosis with the Use of Elastography in Paediatric Patients with Diagnosed Cystic Fibrosis. Disease Markers 2022; 2022: 1 doi: 10.1155/2022/4798136
|
| 22 |
Lucile Regard, Clémence Martin, Guillaume Chassagnon, Pierre-Régis Burgel. Acute and chronic non-pulmonary complications in adults with cystic fibrosis. Expert Review of Respiratory Medicine 2019; 13(1): 23 doi: 10.1080/17476348.2019.1552832
|
| 23 |
Jordan S. Sherwood, Jagdeesh Ullal, Katherine Kutney, Kara S. Hughan. Cystic fibrosis related liver disease and endocrine considerations. Journal of Clinical & Translational Endocrinology 2022; 27: 100283 doi: 10.1016/j.jcte.2021.100283
|
| 24 |
Ki-Kwang Oh, Haripriya Gupta, Raja Ganesan, Satya Priya Sharma, Sung-Min Won, Jin-Ju Jeong, Su-Been Lee, Min-Gi Cha, Goo-Hyun Kwon, Min-Kyo Jeong, Byeong-Hyun Min, Ji-Ye Hyun, Jung-A Eom, Hee-Jin Park, Sang-Jun Yoon, Mi-Ran Choi, Dong Joon Kim, Ki-Tae Suk. The seamless integration of dietary plant-derived natural flavonoids and gut microbiota may ameliorate non-alcoholic fatty liver disease: a network pharmacology analysis. Artificial Cells, Nanomedicine, and Biotechnology 2023; 51(1): 217 doi: 10.1080/21691401.2023.2203734
|
| 25 |
L. Regard, H. Lafoeste, C. Martin, G. Chassagnon, P.-R. Burgel. Vieillir avec la mucoviscidose : comorbidités classiques et émergentes chez l’adulte mucoviscidosique. Revue de Pneumologie Clinique 2018; 74(5): 279 doi: 10.1016/j.pneumo.2018.09.012
|
| 26 |
Alexander J. Towbin, Wen Ye, Suiyuan Huang, Boaz W. Karmazyn, Jean P. Molleston, Prakash Masand, Daniel H. Leung, Samuel Chang, Michael R. Narkewicz, Adina L. Alazraki, A. Jay Freeman, Randolph K. Otto, Nicole Green, Ihab R. Kamel, Wikrom W. Karnsakul, John C. Magee, Jean Tkach, Joseph J. Palermo. Prospective study of quantitative liver MRI in cystic fibrosis: feasibility and comparison to PUSH cohort ultrasound. Pediatric Radiology 2023; 53(11): 2210 doi: 10.1007/s00247-023-05706-6
|